Hinge Health HNGE
NYSE HNGE
$92.45 +1.63 (+1.79%)
At close: Sep 4, 2026 · 4:00 PM EDT

Hinge Health (HNGE) EV to EBITDA (2025 - 2026)

Hinge Health's (HNGE) quarterly EV to EBITDA came in at 154.98 in Q2 2026, up 2491.22% year-over-year from 5.98 in Q2 2025, and up 86.49% quarter-over-quarter from 83.1 in Q1 2026.

Analysis

Hinge Health (HNGE) EV to EBITDA (2025 - 2026) Analysis & Trends

Hinge Health has disclosed EV to EBITDA across 2 years of filings, most recently posting 154.98 for Q2 2026.

  • In Q2 2026, EV to EBITDA rose 2491.22% year-over-year to 154.98; the TTM figure through Jun 2026 stood at 66.91 (up 1078.64% YoY), while the FY2025 annual figure was 6.06, changed N/A from the prior year.
  • EV to EBITDA came in at 154.98 for Q2 2026 at Hinge Health, up from 83.1 in the prior quarter.
  • In the past five years, EV to EBITDA ranged from a high of 154.98 in Q2 2026 to a low of 555.3 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Hinge Health 7.41 Bn 7.03 Bn 183.95 Mn
2 Hims & Hers Health 6.47 Bn 5.63 Bn 480.80 Mn
3 Ethos Technologies 2.54 Bn 2.37 Bn 185.54 Mn
4 Omada Health 1.38 Bn 1.16 Bn 63.79 Mn
5 Teladoc Health 1.14 Bn 366.41 Mn 416.09 Mn
6 Talkspace 870.58 Mn 779.48 Mn 24.80 Mn
7 Akso Health 259.44 Mn 259.25 Mn -
8 LifeMD 147.29 Mn 147.29 Mn -
9 eHealth 31.71 Mn -69.34 Mn -
10 Mangoceuticals 7.39 Mn 7.14 Mn 44,215.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 154.98
Mar 31, 2026 83.10
Dec 31, 2025 121.57
Sep 30, 2025 -555.30
Jun 30, 2025 -6.48